Tharimmune, Inc. (THAR) Insider Trading Activity

NASDAQ$5.14
Market Cap
$203.18M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
185 of 883
Rank in Industry
108 of 506

THAR Insider Trading Activity

THAR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$593,424
4
100
Sells
$0
0
0

Related Transactions

Gravitas Capital LPExecutive Chairman
1
$500,000
0
$0
$500,000
Appajosyula SireeshChief Executive Officer
1
$90,973
0
$0
$90,973
Parikh Sanamdirector
2
$2,451
0
$0
$2,451

About Tharimmune, Inc.

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

Insider Activity of Tharimmune, Inc.

Over the last 12 months, insiders at Tharimmune, Inc. have bought $593,424 and sold $0 worth of Tharimmune, Inc. stock.

On average, over the past 5 years, insiders at Tharimmune, Inc. have bought $314,071 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Gravitas Capital LP (Executive Chairman) — $500,000. Appajosyula Sireesh (Chief Executive Officer) — $90,973. Parikh Sanam (director) — $2,451.

The last purchase of 337,838 shares for transaction amount of $500,000 was made by Gravitas Capital LP (Executive Chairman) on 2025‑06‑20.

List of Insider Buy and Sell Transactions, Tharimmune, Inc.

2025-06-20PurchaseGravitas Capital LPExecutive Chairman
337,838
14.0238%
$1.48
$500,000
+117.16%
2025-06-20PurchaseAppajosyula SireeshChief Executive Officer
61,496
2.5515%
$1.48
$90,973
+117.16%
2025-06-20PurchaseParikh Sanamdirector
1,000
0.0407%
$1.45
$1,450
+117.16%
2025-05-15PurchaseParikh Sanamdirector
770
0.0284%
$1.30
$1,001
+109.77%
2024-12-19PurchaseMILBY RANDYCEO
4,600
0.3052%
$2.12
$9,752
-9.76%
2024-11-13PurchaseAppajosyula SireeshChief Operating Officer
5,000
0.3266%
$2.02
$10,096
-13.07%
2024-10-08PurchaseMILBY RANDYCEO
2,500
0.1689%
$2.09
$5,221
-6.65%
2024-10-08PurchaseAppajosyula SireeshChief Operating Officer
5,000
0.3122%
$1.93
$9,650
-6.65%
Total: 8
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Gravitas Capital LPExecutive Chairman
732424
1.8528%
$3.76M10
Appajosyula SireeshChief Executive Officer
64868
0.1641%
$333,421.5230
<0.0001%
Parikh Sanamdirector
1770
0.0045%
$9,097.8020
MILBY RANDYCEO
17534
0.0444%
$90,124.7620
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$22,693,451
105
8.15%
$200.51M
$16,259,194
41
120.51%
$182.45M
$18,752,549
33
-28.39%
$187.68M
$448,999,793
15
-19.99%
$193.91M
$135,812,721
14
17.52%
$181.35M
$13,259,565
14
-30.38%
$204.65M
$4,701,608
14
-4.34%
$228.4M
$1,037,470
13
78.00%
$215.38M
$6,847,110
9
5.96%
$213.78M
$119,804,612
8
-17.22%
$226.58M
$5,905,507
7
2.69%
$194.8M
$99,355,998
7
-65.74%
$200.5M
$8,286,963
6
3.09%
$225.91M
$20,729,984
5
51.71%
$181.42M
$32,007,657
4
-45.65%
$212.39M
$16,003,671
3
55.38%
$212.69M
Tharimmune, Inc.
(THAR)
$19,848
2
-11.42%
$203.18M
$12,750
2
-39.73%
$207.36M
$63,731
1
-19.50%
$178.57M

THAR Institutional Investors: Active Positions

Increased Positions00%00%
Decreased Positions00%00%
New Positions0New0New
Sold Out Positions0Sold Out0Sold Out
Total Postitions00%00%

THAR Ownership Change vs Market

No data is available at this moment.

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$2,244.001.84%663,882+663,882New2025-09-30
Vanguard Group Inc$157.000.13%46,332+46,332New2025-09-30
Geode Capital Management, Llc$94.000.08%27,932+12,566+81.78%2025-09-30
Franklin Resources Inc$85.000.07%25,000-20,000-44.44%2025-09-30
State Street Corp$59.000.05%17,521+17,521New2025-09-30
Drucker Wealth 3.0, Llc$34.000.03%10,135+10,135New2025-09-30
Citigroup Inc$34.000.03%9,928+9,928New2025-09-30
Pnc Financial Services Group, Inc.$7.000.01%2,000+2,000New2025-09-30
Sbi Securities Co., Ltd.$5.00<0.01%1,525-3-0.2%2025-09-30
Ubs Group Ag$3.00<0.01%833-14,169-94.45%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.